Navigation Links
Global Stem Cells Group Announces New Clinic Opening in Quito, Ecuador
Date:2/11/2016

Global Stem Cells Group, has announced the opening of its new stem cell treatment clinic in Quito, Ecuador. The new facility will provide advanced protocols and state-of-the-art techniques in cellular medicine, focusing on orthopedic and trauma applications to patients from around the world.

The new GSCG clinic is headed by four prominent Ecuadorian physicians, including Pablo Ramos, M.D. an orthopedic specialist and attending physician at Metropolitan Hospital in Quito; Pablo Cornejo, M.D., a specialist in orthopedic and trauma surgery at Metropolitan Hospital, Quito; Luis Ernesto Mantilla, M.D., a specialist in traumatology and knee Surgery, and at Metropolitan Hospital, Quito and Alberto Ramos, M.D., a specialist in orthopedic surgery, traumatology and arthroscopy at Metropolitan Hospital, Quito.

The opening of the Quito stem cell clinic marks Global Stem Cells Group’s first facility in Ecuador, and is part of GSCG’s expanding presence in Latin America.

Global Stem Cells Group has been expanding its clinical presence worldwide by partnering with qualified physicians experienced in stem cell therapies to open new clinics, licensed and developed under the GSCG banner.

Global Stem Cells Group provides stem cell treatments for a variety of conditions and diseases including arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes, multiple sclerosis, injuries and more at various facilities worldwide. The new facility in Quito will have an international staff that is experienced in administering the leading cellular therapies available.

Global Stem Cells Group’s Quito clinic is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. GSCG clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.

The Global Stem Cells Group is committed to providing the highest of standards of services and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.

For more information, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call +1 305 560 5337.

About the Global Stem Cell Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

###

Read the full story at http://www.prweb.com/releases/GlobalStemCellsGroup/QuitoEcuadorClinicOpening/prweb13209900.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. Regeneron Joins Human Vaccines Project to Improve Global Disease Prevention and Treatment
2. Global Stem Cells Group Announces Agreement with Singapore Stem Cell Training Network
3. Cenna Biosciences Inc. Selected to Present at Cavendish Global Health Impact Forum
4. Creation Technologies Achieves ISO 13485 Certification in All Global Manufacturing and Design Locations
5. Microbiology Culture Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023
6. Shire Marks 30th Anniversary with Innovative Global Program to Benefit Children with Rare Diseases
7. Sangamo BioSciences Announces Presentation At The Leerink Partners 5th Annual Global Healthcare Conference
8. Ascendis Pharma A/S to Present at the Leerink Partners Global Healthcare Conference
9. Global Pneumatic Tube System Provider Aerocom Establishes North American Office to Focus on Hospital Market
10. Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2023
11. qPCR Reagents Market by Detection, Packaging, End User, Application - Global Forecasts to 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/19/2019)... ... 19, 2019 , ... The AACR annual conference pulls together a diverse group ... cutting-edge cancer research. The Visikol team will be at the show at booth #3252 ... well as their digital pathology services . “For AACR this year we are ...
(Date:3/19/2019)... ... March 19, 2019 , ... Cirrascale Cloud ... it has extended its managed services offering to include NVIDIA® DGX™ systems. The ... part of the NVIDIA DGX-Ready Data Center program to deliver a Zero DevOps ...
(Date:3/19/2019)... ... ... old when he injured both of his cruciate ligaments. On top of that, Bogey ... with his mobility. According to his owners, he could barely walk and required assistance ... owners, devastated at the sight of Bogey in so much pain and the possibility that ...
(Date:3/19/2019)... ... March 19, 2019 , ... Konica Minolta Precision Medicine, ... formation of their inaugural Scientific Advisory Board. , Founded in late ... account individual variability in genes, environment, and lifestyle to more accurately predict, detect, ...
Breaking Biology Technology:
(Date:3/9/2019)... ... ... Murrieta Genomics , the genomic sequencing business incubator, is pleased to be ... Riverside’s EPIC SBDC focused on research funding by U.S. Small Business Administration. The event ... The location is the Highlander Union Building, Room 302 South on the University of ...
(Date:3/9/2019)... , ... March 08, 2019 , ... ... its first consumer product, Well-Mints™ resveratrol + ribose hard candy lozenges ( http://www.well-mints.com ... ribose in a naturally flavored hard candy base dusted with powdered sugar. , ...
(Date:3/1/2019)... ... , ... Teresa Krabbe, Ph.D., a student in the working group of Dr. ... awarded an xCELLigence Research Grant for her proposal to develop adoptive T cell therapy ... viruses represent an exciting new aspect in the evolving field of cancer immunotherapy. Dr. ...
Breaking Biology News(10 mins):